Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 7

1.

Translating Treg Therapy in Humanized Mice.

Hahn SA, Bellinghausen I, Trinschek B, Becker C.

Front Immunol. 2015 Dec 14;6:623. doi: 10.3389/fimmu.2015.00623. eCollection 2015. Review.

2.

Interferon-Beta Therapy of Multiple Sclerosis Patients Improves the Responsiveness of T Cells for Immune Suppression by Regulatory T Cells.

Trinschek B, Luessi F, Gross CC, Wiendl H, Jonuleit H.

Int J Mol Sci. 2015 Jul 17;16(7):16330-46. doi: 10.3390/ijms160716330.

3.

FTY720 (fingolimod) treatment tips the balance towards less immunogenic antigen-presenting cells in patients with multiple sclerosis.

Luessi F, Kraus S, Trinschek B, Lerch S, Ploen R, Paterka M, Roberg T, Poisa-Beiro L, Klotz L, Wiendl H, Bopp T, Jonuleit H, Jolivel V, Zipp F, Witsch E.

Mult Scler. 2015 Dec;21(14):1811-22. doi: 10.1177/1352458515574895. Epub 2015 Mar 2.

PMID:
25732840
4.

Cladribine exerts an immunomodulatory effect on human and murine dendritic cells.

Kraus SH, Luessi F, Trinschek B, Lerch S, Hubo M, Poisa-Beiro L, Paterka M, Jonuleit H, Zipp F, Jolivel V.

Int Immunopharmacol. 2014 Feb;18(2):347-57. doi: 10.1016/j.intimp.2013.11.027. Epub 2013 Dec 5.

PMID:
24316255
5.

Kinetics of IL-6 production defines T effector cell responsiveness to regulatory T cells in multiple sclerosis.

Trinschek B, Luessi F, Haas J, Wildemann B, Zipp F, Wiendl H, Becker C, Jonuleit H.

PLoS One. 2013 Oct 14;8(10):e77634. doi: 10.1371/journal.pone.0077634. eCollection 2013. Erratum in: PLoS One. 2013;8(11). doi: 10.1371/annotation/0e76c09e-75b2-493a-90fd-cda3187a0888. L├╝ssi, Felix [corrected to Luessi, Felix].

6.

Subclinical CNS inflammation as response to a myelin antigen in humanized mice.

Zayoud M, El Malki K, Frauenknecht K, Trinschek B, Kloos L, Karram K, Wanke F, Georgescu J, Hartwig UF, Sommer C, Jonuleit H, Waisman A, Kurschus FC.

J Neuroimmune Pharmacol. 2013 Sep;8(4):1037-47. doi: 10.1007/s11481-013-9466-4. Epub 2013 May 3.

PMID:
23640521
7.

Costimulatory molecules on immunogenic versus tolerogenic human dendritic cells.

Hubo M, Trinschek B, Kryczanowsky F, Tuettenberg A, Steinbrink K, Jonuleit H.

Front Immunol. 2013 Apr 3;4:82. doi: 10.3389/fimmu.2013.00082. eCollection 2013.

Supplemental Content

Loading ...
Support Center